Resolve, Regarding Legislative Review Of Chapter 800: Uniform Reporting Of Wholesale Acquisition Costs For Insulin, A Major Substantive Rule Of The Maine Health Data Organization

LD 729 is a legislative resolve authorizing the final adoption of Chapter 800, a rule requiring uniform reporting of wholesale insulin costs by manufacturers. This rule, submitted for review by the Maine Health Data Organization, directly affects insulin manufacturers and healthcare providers who report cost data. The resolve bypasses the standard 90-day waiting period (via emergency status) to formally approve the rule, as required by Maine law before major agency rules can take effect. It does not change insulin pricing or reporting requirements but confirms legislative approval of the existing rule.